These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31700183)

  • 1. Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans.
    Gómez-Banoy N; Guseh JS; Li G; Rubio-Navarro A; Chen T; Poirier B; Putzel G; Rosselot C; Pabón MA; Camporez JP; Bhambhani V; Hwang SJ; Yao C; Perry RJ; Mukherjee S; Larson MG; Levy D; Dow LE; Shulman GI; Dephoure N; Garcia-Ocana A; Hao M; Spiegelman BM; Ho JE; Lo JC
    Nat Med; 2019 Nov; 25(11):1739-1747. PubMed ID: 31700183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipsin is an adipokine that improves β cell function in diabetes.
    Lo JC; Ljubicic S; Leibiger B; Kern M; Leibiger IB; Moede T; Kelly ME; Chatterjee Bhowmick D; Murano I; Cohen P; Banks AS; Khandekar MJ; Dietrich A; Flier JS; Cinti S; Blüher M; Danial NN; Berggren PO; Spiegelman BM
    Cell; 2014 Jul; 158(1):41-53. PubMed ID: 24995977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Analysis of Restored Insulin Production and Trafficking in Obese Diabetic Mouse Pancreatic Islets Following Euglycemia.
    Kang T; Boland BB; Alarcon C; Grimsby JS; Rhodes CJ; Larsen MR
    J Proteome Res; 2019 Sep; 18(9):3245-3258. PubMed ID: 31317746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P preserves pancreatic β-cells in type 1 and type 2 diabetic mice.
    Um J; Jung N; Kim D; Choi S; Lee SH; Son Y; Park KS
    Biochem Biophys Res Commun; 2018 May; 499(4):960-966. PubMed ID: 29626466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dracorhodin perchlorate protects pancreatic β-cells against glucotoxicity- or lipotoxicity-induced dysfunction and apoptosis in vitro and in vivo.
    Liu L; Liang C; Mei P; Zhu H; Hou M; Yu C; Song Z; Bao Y; Huang Y; Yi J; Wang S; Wu Y; Zheng L; Sun Y; Wang G; Huo M; Yang S; Sun L; Li Y
    FEBS J; 2019 Sep; 286(18):3718-3736. PubMed ID: 31349381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
    Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
    J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
    Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
    J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Goto-Kakizaki (GK) Rat Model of Type 2 Diabetes.
    Guest PC
    Methods Mol Biol; 2019; 1916():203-211. PubMed ID: 30535697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3Kγ ablation does not promote diabetes in
    Breasson L; Sardi C; Becattini B; Zani F; Solinas G
    FASEB J; 2018 Jan; 32(1):319-329. PubMed ID: 28904022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic overexpression of active calcineurin in beta-cells results in decreased beta-cell mass and hyperglycemia.
    Bernal-Mizrachi E; Cras-Méneur C; Ye BR; Johnson JD; Permutt MA
    PLoS One; 2010 Aug; 5(8):e11969. PubMed ID: 20689817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonist.
    Kanda Y; Shimoda M; Hamamoto S; Tawaramoto K; Kawasaki F; Hashiramoto M; Nakashima K; Matsuki M; Kaku K
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E278-86. PubMed ID: 19920213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Pten in pancreatic ß-cells protects against deficient ß-cell mass and function in mouse models of type 2 diabetes.
    Wang L; Liu Y; Yan Lu S; Nguyen KT; Schroer SA; Suzuki A; Mak TW; Gaisano H; Woo M
    Diabetes; 2010 Dec; 59(12):3117-26. PubMed ID: 20852026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klf6 protects β-cells against insulin resistance-induced dedifferentiation.
    Dumayne C; Tarussio D; Sanchez-Archidona AR; Picard A; Basco D; Berney XP; Ibberson M; Thorens B
    Mol Metab; 2020 May; 35():100958. PubMed ID: 32244185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion.
    Tanuma N; Nomura M; Ikeda M; Kasugai I; Tsubaki Y; Takagaki K; Kawamura T; Yamashita Y; Sato I; Sato M; Katakura R; Kikuchi K; Shima H
    Oncogene; 2009 Feb; 28(5):752-61. PubMed ID: 19043453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 normalizes hyperglycemia by stimulating β-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2).
    Zhao Z; Choi J; Zhao C; Ma ZA
    J Biol Chem; 2012 Feb; 287(8):5562-73. PubMed ID: 22194608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
    Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue-derived adipsin marks human aging in non-type 2 diabetes population.
    Maity SK; Das Sharma A; Sarkar J; Chaudhuri T; Tantia O; Chakrabarti P
    BMJ Open Diabetes Res Care; 2024 Aug; 12(4):. PubMed ID: 39209774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipsin deficiency does not impact atherosclerosis development in
    Liu L; Chan M; Yu L; Wang W; Qiang L
    Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E87-E92. PubMed ID: 33135458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.